Article
The association between CD14-260C/T polymorphism and malignant tumor risk: a meta-analysis of 5,603 participants.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Sept 2014
Tong Xiang, Li Zhenzhen, Fu Xiaowei, Zhou Kai, Wu Yao, Zhang Yonggang, Fan Hong
Abstract excerpt
The CD14-260C/T polymorphism has been implicated to be in association with malignant tumor. However, a number of studies have reported inconclusive results. The aim of this study was to investigate the relationship of CD14-260C/T polymorphism and malignant tumor risk by meta-analysis. A search was performed in PubMed, Embase, the Chinese Journals Full-text Database (CNKI), and Wanfang databases up to August 2013....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
